Chat with us, powered by LiveChat

Prefilled Syringes Market (Type - Disposable Prefilled Syringes, and Reusable Prefilled Syringes; Material Type - Glass Prefilled Syringes, and Plastic Prefilled Syringes; Design - Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes; Application - Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, and Others; Distribution Channel - Hospital Pharmacies, Retail Pharmacies & Drug Stores, and E-Commerce): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Prefilled Syringes Market (Type - Disposable Prefilled Syringes, and Reusable Prefilled Syringes; Material Type - Glass Prefilled Syringes, and Plastic Prefilled Syringes; Design - Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes; Application - Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, and Others; Distribution Channel - Hospital Pharmacies, Retail Pharmacies & Drug Stores, and E-Commerce): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Report Code: IGR0182 Category: Healthcare & Medical Devices Published: October, 2023

A recent report published by Infinium Global Research on prefilled syringes market provides in-depth analysis of segments and sub-segments in the global as well as regional prefilled syringes market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional prefilled syringes market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global prefilled syringes market.

Market Insight:

The global prefilled syringes market was valued at USD 18.42 billion in 2022 and is expected to reach USD 54.06 billion in 2030, with a CAGR of 12.48% during the forecast period 2023-2030.

A prefilled syringe is a medical device designed to contain a precisely measured dose of medication or vaccine, ready for immediate use. These syringes are pre-loaded with an accurate quantity of the drug or vaccine, ensuring sterility and integrity, and can be constructed from either glass or plastic, often featuring an attached needle or needle-free delivery system. The primary focus of prefilled syringes is to enhance patient safety and convenience. They have emerged as a vital component in modern healthcare due to several benefits, including the elimination of manual dose preparation by healthcare professionals, reducing of contamination risks and needle-related injuries. Furthermore, prefilled syringes empower self-administration, enabling patients to manage their treatments at home, thereby improving medication adherence and relieving the strain on healthcare facilities. In sum, the adoption of prefilled syringes represents a significant advancement in the healthcare sector, contributing to safer and more efficient medical practices.

The increased emphasis on minimizing medication errors and enhancing dosing precision has accelerated the adoption of prefilled syringes. These syringes offer pre-measured, ready-to-administer doses, reducing the risk of human error and ensuring accurate drug delivery, making them a crucial component of patient safety and healthcare efficiency. Additionally, pre-filled syringes offer enhanced convenience for patients, enabling easier self-administration. For healthcare providers, they streamline processes and improve efficiency. These advantages drive the pre-filled syringe market's growth, positioning them as a preferred solution in drug delivery and patient care. However, the pre-filled syringe market faces challenges from stringent government regulations, competition from alternative drug delivery methods, and occasional product recalls, which can impede its growth. Although, the increasing incidence of chronic illnesses and the rising demand for biopharmaceuticals are providing significant growth opportunities for the pre-filled syringe market. Prefilled syringes offer precise and convenient drug delivery, making them an ideal choice for administering complex biologic medications, thus driving their adoption in the healthcare sector.

Prefilled Syringes Market Size, Share, Trends, Industry | IGR

Europe holds the largest market share in the global prefilled syringes market. The region's well-established healthcare infrastructure, stringent regulatory framework, and a growing aging population contributed to the substantial market share. European countries such as Germany, France, and the United Kingdom played key roles in driving market growth. Moreover, the Asia-Pacific is the fastest-growing market for prefilled syringes. This growth is propelled by factors such as increasing healthcare investments, rising healthcare awareness, and a growing demand for self-administration of medications. Countries such as China, India, and Japan are at the forefront of this growth. Additionally, the region's large population and expanding pharmaceutical industry made it an attractive market for prefilled syringe manufacturers.

Report Scope of the Prefilled Syringes Market:

Report Coverage Details
Market Size in 2022 USD 18.42 Billion
Market Size by 2030 USD 54.06 Billion
Growth Rate from 2023 to 2030 CAGR of 12.48%
Largest Market Europe
No. of Pages 350
Market Drivers
  • Increased focus on reducing medication errors and improving dosing accuracy is boosting prefilled syringe adoption.

  • Enhanced patient convenience and healthcare provider efficiency are contributing to the prefilled syringe market's growth.

Market Segmentation By Type, By Material Type, By Design, By Application, and By Distribution Channel
Regional Scope North America, Europe, Asia Pacific, and RoW

Segment Covered

The report on global prefilled syringes market covers segments such as type, material type, design, application, and distribution channel. On the basis of type, the sub-markets include disposable prefilled syringes, and reusable prefilled syringes. On the basis of material type, the sub-markets include glass prefilled syringes, and plastic prefilled syringes. On the basis of design, the sub-markets include single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. On the basis of application, the sub-markets include diabetes, rheumatoid arthritis, anaphylaxis, cancer, and others. On the basis of distribution channel, the sub-markets include hospital pharmacies, retail pharmacies & drug stores, and e-commerce.

Companies Profiled:

The report provides profiles of the companies in the market such as West Pharmaceutical Services, Taj Pharma Group, SCHOTT AG, NIPRO, Baotou KONRE Pharma Glass Packaging Co.,Ltd., Gerresheimer AG, MedXL Inc., Baxter, Pfizer Inc., and Owen Mumford.

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the prefilled syringes market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Frequently Asked Questions (FAQ's)

The global prefilled syringes market was valued at USD 18.42 Billion in 2022.
It is likely to grow at a CAGR of 12.48% during the forecast period 2023-2030.
The global prefilled syringes market is estimated to reach USD 54.06 Billion by the end of 2030.
Europe is anticipated to exhibit high demand for prefilled syringes market during the forecast period.
West Pharmaceutical Services, Taj Pharma Group, SCHOTT AG, NIPRO, Baotou KONRE Pharma Glass Packaging Co.,Ltd., Gerresheimer AG, MedXL Inc., Baxter, Pfizer Inc., and Owen Mumford.
CHOOSE LICENCE TYPE

Please Choose One of them.

Google translate
© 2024. Infinium Global Research LLP. All Rights Reserved.